AbbVie buys cancer-focused Mavupharma
AbbVie Inc. has acquired closely held Mavupharma for an undisclosed sum.
- Drug Discovery Tools
- Acquisition of Private Biotech
- Full Acquisition
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.